At Mariana Oncology, a Novartis company, we believe we are on the cusp of a paradigm shift in cancer care: precision radioligand therapies designed to optimize efficacy while allowing patients to live better during their treatment journey.
Purpose & innovation
Receiving a cancer diagnosis can be frightening for patients—treatment shouldn’t be. At Mariana Oncology, a Novartis company, we are committed to changing not just how we treat cancer, but how patients experience that treatment journey. We are leading the development of a new generation of radioligand therapies designed to selectively deliver radioisotopes to diseased cells while minimizing impact on healthy tissue.
Programs & pipeline
Each day we ask ourselves: "What will it take to improve the way we treat cancer? What improvements will make the greatest impact on the lives of patients?" At Mariana Oncology, a Novartis company, we are advancing a pipeline of precision radioligand therapies designed to pursue compelling cancer targets with the aim of treating some of today’s most challenging cancers.
Team & careers
Innovation and transformation require new ways of thinking and working, of pushing boundaries to pursue aggressive goals and execute with excellence. We work with purpose and passion; we act with intention and urgency. It’s been an incredible journey so far, and we’re just getting started.
